The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has approved the company’s oncology drug, Nelarabine Injection, ...
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage for ...
In Table 1, we describe six broad strategies that can be used to lower cancer drug dosing and reduce drug waste, many of which have already been clinically validated. Intravenous (IV) drug waste is ...
Eli Lilly is cutting what self-paying patients shell out for its blockbuster obesity drug Zepbound when they buy single-dose vials directly through its own online pharmacy. The move reshapes the cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results